David C. Cavalier's most recent trade in Anixa Biosciences Inc was a trade of 30,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 13, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Anixa Biosciences Inc | David C. Cavalier | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2020 | 30,000 | 30,000 | - | - | Employee Stock Option (Right to Buy) |